Jennifer O’Farrell is a partner in the Biotechnology and Life Sciences group. She has experience prosecuting patent applications before the European Patent Office in all aspects of life sciences and biotechnology, with a particular focus on bacterial vaccines, apoptotic regulation, immunology, ubiquitin proteases, DNA sequencing and pegylation technologies. O’Farrell also has experience in attacking and defending patents during opposition proceedings before the EPO, managing clients’ international patent portfolios, advising on filing strategies and prosecuting patent applications before the UKIPO. She has been extensively involved in the filing of SPC applications throughout Europe.